Last updated on April 19, 2014 at 18:42 EDT

Equity Research for Intel, Pfizer, A123 Systems, J.C. Penney, Delta Air Lines, and DIRECTV

June 13, 2012

VANCOUVER, British Columbia, June 13, 2012 /PRNewswire-Asia/ — Pennystocksinsiders.com (PSI) has issued insider trading reports and Equity Research for the following companies: Intel (NASDAQ:INTC), Pfizer (NYSE:PFE), A123 Systems (NASDAQ:AONE), J.C. Penney (NYSE:JCP), Delta Air Lines (NYSE:DAL), and DIRECTV (NASDAQ:DTV).

(Logo: http://photos.prnewswire.com/prnh/20120531/HK16417LOGO)

(Read full report by clicking the link below, you may need to copy and paste the full link to your browser.)

Report Highlights:

Intel Corporation (NASDAQ:INTC): Intel increased 2.06% to US$26.52 on over 29.13 million shares, well above its average volume of 37.63 million shares. The chip designer ARM deployed its processors into smartphone and tablet market, these electronic devices can benefit from the energy-efficient architecture. Intel, the PC market giant, re-launched its smartphone market strategy early this year. “Intel’s phones were still a couple of generations behind the latest ARM-based smartphones,” said by Warren East, chief executive of Cambridge-based ARM. Pennystocksinsiders.com thinks that it is a clever way to check if insiders like CEOs, CFOs, and Directors in INTC are starting to buy more company shares. See insider trade report for INTC here.

Read Full Report: http://www.Pennystocksinsiders.com/PR/061312A/INTC/Intel.pdf

Pfizer, Inc. (NYSE:PFE): Pfizer’s share price rose 0.41% to US$22.19 with more than 24.63 million shares, compared to its average volume of 37.10 million shares. In the past 52 weeks, Pfizer share prices have been bracketed by a low of US$16.63 and a high of US$23.30 and are now at US$22.19, 4.76% below that high price of April 2012. Pfizer’s Effexor XR is venlafaxine hydrochloride which is used to treat depression and anxiety disorders. From January to March, its global sales recorded as US$129 million which fell 37% from a year earlier. Are insiders starting to take huge profits by selling shares or exercising stock options? Academic studies have shown that insiders traditionally make higher investment returns than ordinary investors. Want to find out how they do it?

Read Full Report: http://www.Pennystocksinsiders.com/PR/061312A/PFE/Pfizer.pdf

A123 Systems, Inc. (NASDAQ:AONE): A123 Systems gained 51.92% to US$1.58 on over 35.22 million shares, compared to its average volume of 1.59 million shares. A123 Systems announced that they have a new lithium ion battery technology which can work in extreme temperature environment without thermal management. The company said it will create new opportunities in transportation and telecommunications markets. Do you want to spend less time on picking stocks and raise your return at the same time? Academic studies have shown that insiders traditionally make higher investment returns than ordinary investors. Want to trace the activities of company insiders from now on?

Read Full Report: http://www.Pennystocksinsiders.com/PR/061312A/AONE/A123Systems.pdf

Today Pennystocksinsiders.com also observed abnormal trade volume for the following companies; insiders may involve trading in these companies. It will take some time for insiders to report their trades. Read these reports and add these companies into your Insider Trade Radar

J.C. Penney Company, Inc. (NYSE:JCP):

Read Full Report: http://www.Pennystocksinsiders.com/PR/061312A/JCP/JCPenney.pdf

Delta Air Lines, Inc. (NYSE:DAL):

Read Full Report: http://www.Pennystocksinsiders.com/PR/061312A/DAL/DeltaAirLines.pdf


Read Full Report: http://www.Pennystocksinsiders.com/PR/061312A/DTV/DIRECTV.pdf

Insider Filing Source Reference: All observations, analysis and reports are based on public information released by the U.S. Securities and Exchange Commission.

About Pennystocksinsiders.com:

Pennystocksinsiders.com features a team of experienced data analysts striving to provide the investment community with the tools, software, and data necessary to carry out more effective investment research.

Important Disclaimer:

Please visit Pennystocksinsiders.com/disclaimers/index.php for details.

SOURCE Pennystocksinsiders.com

Source: PR Newswire